NOVPUB
Chapter 1433: Chapter 1279: Can’t Sit Still Anymore (Please Subscribe!)
As Forbes’ Huaxia list was released,
the outside world,
began to shift focus.
Many were eagerly anticipating whether, in March next year, Tang Qing might dethrone Bill Gates in the Forbes’ World Rich List and become the first Chinese tycoon among the global top three.
Meanwhile,
many Westerners let out a sigh of relief.
Luckily,
they had ERV.
A company so highly valued it seemed absurd.
Otherwise,
the title of the world’s wealthiest might have been occupied by a Chinese, which was something they found unacceptable. God bless America, Tang Qing was ultimately destined to be trampled by ERV.
Overturn the status quo?
Easier said than done.
With such a mindset,
ERV
rose to the level of a national hero.
After the market opened in the morning,
it even began to experience a slight rise. American pride, it seemed, could only be preserved by ERV; hence everyone wanted to contribute their effort, and the pre-orders for ERV’s smartphones skyrocketed.
Still not on the market,
yet they reached more than four million eighty thousand units.
They,
were determined to suppress ’Epoch’. As for other companies’ smartphones, there were few inquiries, for buying them wouldn’t push Tang Qing out of the top three anyway, so why not support ERV?
Some thought of citing national information security
to boycott ’Epoch’.
But remembering the previous incident,
where they were sued en masse for being ’ungrateful’ by ERV, they quieted down. Well, it seems as long as ’Epoch’ uses ERV’s processors and system, ERV has to protect ’Epoch’.
Nevermind.
After all, ERV controlled the lifeline of ’Epoch’.
Let there be fair competition.
They don’t believe,
they can’t defeat ’Epoch’.
...
At this time,
in Huaxia,
various institutions such as the Ministry of Health and the Chinese Academy of Sciences,
were discussing a major issue.
"After three months of experiments, we can tentatively conclude that the Transcription Fluid has noticeable and side effect-free cancer treatment effects. The clinical records and experimental data provided by the Myanmar Pharmaceutical Group are all accurate and correct."
"This substance has extremely strong gene stability, not only effective against cancer but also shows significant effectiveness against common blood-related and immune system diseases, akin to a nemesis of abnormal cells."
"So, does this mean we can start clinical treatments in Huaxia?"
"Yes, this way, we can collect more clinical data, but in the spirit of safety, we do not recommend a large-scale release domestically, only for use with critically ill patients," suggested a biology academician.
To date,
Myanmar Pharmaceutical Group has shown no intention of disclosing the preparation method of Transcription Fluid, unlike the Filtering Solution for which they had mastered the technology, although at too high a cost for commercialization.
But for Transcription Fluid,
they were clueless.
This magical form,
had no chemical structure,
but resembled a supermaterial form -- they truly had no idea how it was prepared, and as it was not a domestic company, they could not just share the technology.
Originally,
according to the plan,
they would need at least over a year, even several years of experiments before possibly allowing Transcription Fluid clinical treatments in Huaxia, but orders from above asked them to speed up.
Reason,
unknown.
Experts were unaware,
but those who listened to the reports were well aware that according to their knowledge, nearly six million appointments had been made from Huaxia with the Myanmar Pharmaceutical Group, and the numbers were still rising.
At this rate,
based on an average treatment fee of fifty thousand per person,
it would exceed three hundred billion RMB.
And that’s just the treatment expenses.
Including food, accommodations, and other expenditures there, it could nearly reach five hundred billion RMB, and that’s just for one trip’s price, not factoring in annual check-ups and revisits.
Secondary expenditures, tourism...
Goodness.
In the next five years,
just Huaxia alone,
could generate over a trillion RMB in GDP for Myanmar, and that’s just from consumer spending, to say nothing of investments and the like, even if the amount doubled, it wouldn’t seem too unreasonable.
Once the economic calculations were made,
many people became restless, not just in Huaxia, but in many other countries as well, especially those with large populations who grieved over this kind of ’capital outflow’.
Therefore,
the leaders specifically inquired about this issue.
Quickly,
a resolution was passed in the meeting.
--- Preliminary approval was granted for clinical treatment with Transcription Fluid; major hospitals were to draw on their best resources to learn how to use Transcription Fluid in Myanmar as quickly as possible to build up a treatment capability, with the specific details to be negotiated by Huaxia’s Ministry of Health.
...
November 5,
Monday,
Beijing.
A joint inspection team, comprising the Ministry of Health, the Chinese Academy of Sciences, and other departments, along with Sun Jiang, Huaxia’s Envoy to Myanmar, boarded a newly added flight to Nay Pyi Taw.
A few days ago,
Sun Jiang personally delivered that thick proposal back.
Currently,
Huaxia’s Central Bank, the Securities Regulatory Commission, the Banking Regulatory Commission, and several other financial departments were discussing it urgently. Given the importance, to come to a conclusion would take at least until the end of this month.
Sun Jiang knew,
it wasn’t that they were slow.
Rather,
the preparations by ’Ling’ were too thorough; even a year ahead, and the mess on their side was expected. This time, he also brought along Huaxia’s gold purchase contract, just waiting for a signature.
...
In the afternoon,
after making preparations, 𝙣𝒐𝙫𝙥𝙪𝙗.𝙘𝙤𝙢
Sun Jiang arrived at the Presidential Palace.
After reviewing the contract,
Ling nodded.
"Happy cooperation, however, I’m not suitable to sign it directly, later, you should go to Myanmar Central Bank, find the bank president to sign it, and then tomorrow, you can arrange the convoy to pick up the goods in Xin’an City."
Ling passed back the contract.
"Understood."
Sun Jiang took the contract,
ready to head to the Myanmar Central Bank shortly thereafter. The president of which, who was also the head of Myanmar Bank and currently the overall in-charge of the Myanmar Bank Group, also held a government position there.
He was a rare influential figure.
"This delegation accompanying me includes representatives from our country’s health sector, who want to further discuss the entry of Transcription Fluid into Huaxia for clinical treatment," Sun Jiang said.
This matter,
was previously informed to the Presidential Office.
It wasn’t a sudden visit.
"Thank you for your country’s trust in our medical technology; for the specifics, you can directly go to Myanmar Pharmaceutical Group, I’ve already instructed them, and they will arrange this negotiation."
"Thank you very much."
Sun Jiang of course understood why Huaxia was somewhat anxious.
Always attracting investments,
yet taken away by others.
It’s ridiculous to simply watch, yet there’s no solution, unlike the Filtering Solution where they could pose conditions: if you don’t come here to manufacture, we’ll just passively promote it since it’s not an essential item.
But for Transcription Fluid,
it’s a matter of life and death.
The users have no choice; no one wants to die, thus Ling could stand firm, opening hospitals at home, and global patients had to come, needing no compromise with anyone.
